Company Filing History:
Years Active: 1991
Title: Ekkehard Schilliner: Innovator in Prostaglandin Derivatives
Introduction
Ekkehard Schilliner is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of prostaglandin derivatives. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.
Latest Patents
Schilliner holds a patent for "Novel 9-haloprostaglandins, processes for their preparation, and their applications." This invention relates to 9-halo-15-cycloalkyl prostaglandin derivatives, which are represented by a specific chemical formula. The patent highlights the potential of these compounds in therapeutic applications, emphasizing their significance in medical research.
Career Highlights
Throughout his career, Schilliner has been associated with Schering Aktiengesellschaft, a prominent pharmaceutical company. His work there has allowed him to focus on innovative research and development, contributing to advancements in drug formulation and delivery. His expertise in prostaglandin chemistry has positioned him as a key figure in this specialized field.
Collaborations
Schilliner has collaborated with esteemed colleagues, including Bernd Raduechel and Werner Skuballa. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research.
Conclusion
Ekkehard Schilliner's contributions to the field of prostaglandin derivatives exemplify the impact of innovation in pharmaceuticals. His patent and collaborative efforts reflect a commitment to advancing medical science and improving patient outcomes.